Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients

BACKGROUND: Psoriasis is immune-mediated chronic inflammatory disease with preference for skin and joints. The skin involvement occurs by hyperproliferation and abnormal differentiation of keratinocytes. It is associated with comorbidities, mainly related to the clinical manifestations of the metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonio, João Roberto, Sanmiguel, Jessica, Cagnon, Giovana Viotto, Augusto, Marília Silveira Faeda, de Godoy, Moacir Fernandes, Pozetti, Eurides Maria Oliveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2016
Materias:
Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938274/
https://www.ncbi.nlm.nih.gov/pubmed/27438197
http://dx.doi.org/10.1590/abd1806-4841.20164292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938274/
https://www.ncbi.nlm.nih.gov/pubmed/27438197
http://dx.doi.org/10.1590/abd1806-4841.20164292

Ejemplares similares